Histopathologic Features for Overall Survival in Merkel Cell Carcinoma: A Case Series with Intact Mismatch Repair Protein Expression
- PMID: 37350641
- PMCID: PMC10521203
- DOI: 10.5146/tjpath.2023.01603
Histopathologic Features for Overall Survival in Merkel Cell Carcinoma: A Case Series with Intact Mismatch Repair Protein Expression
Abstract
Objective: In a study of Merkel cell carcinoma (MCC), a fusion transcript between MLH1 and SPATA4 was identified. This fusion has the potential to generate the inactive or dominant-negative form of the protein. Therefore, we aimed to investigate whether mismatch repair protein deficiency occurr in MCC cases or not, in addition to the overall survival association with histopathologic features.
Material and method: A retrospective review of 15 patients diagnosed with a biopsy-proven Merkel Cell Carcinoma between 2012 and 2019 was performed. Mismatch repair (MMR) protein expressions were evaluated by immunohistochemistry.
Results: The median follow-up time was 36 months (mean 41, range 2-103 months). Six (40%) patients died during follow-up. The overall survival (OS) at 1 year, 2 years, 3 years, and 5 years were 87%, 80%, 62%, and 53%, respectively. The patients diagnosed at < 60 years had an improved OS compared to those ≥60 years of age (p=0.016). Patients in clinical stage I had better OS than patients in clinical stage IV (p=0.011). Cases with pathological tumor stage (pT) 1 had better OS than pT3 and pT4 (p=0.045). Adjuvant radiotherapy or adjuvant radiotherapy+chemotherapy treatment improved OS compared to adjuvant chemotherapy (p=0.003). MMR protein nuclear expression was intact in 12 cases available for immunohistochemical study.
Conclusion: To the best of our knowledge, this is the second study that preferentially investigated the mismatch repair protein status of Merkel Cell Carcinoma. No mismatch repair protein deficiency of MCC cases was identified in the current study.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Merkel cell carcinoma: a clinicopathological study of 11 cases.J Eur Acad Dermatol Venereol. 2005 Sep;19(5):546-51. doi: 10.1111/j.1468-3083.2005.01224.x. J Eur Acad Dermatol Venereol. 2005. PMID: 16164706
-
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.J Natl Cancer Inst. 2016 May 31;108(9):djw042. doi: 10.1093/jnci/djw042. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27245173 Free PMC article.
-
Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma.JAMA Dermatol. 2021 May 1;157(5):540-548. doi: 10.1001/jamadermatol.2021.0247. JAMA Dermatol. 2021. PMID: 33760021 Free PMC article.
-
Systematic literature review of current treatments for stage I-III Merkel cell carcinoma.Future Oncol. 2021 Dec;17(34):4813-4822. doi: 10.2217/fon-2021-0574. Epub 2021 Sep 8. Future Oncol. 2021. PMID: 34494443
-
Merkel cell carcinoma: Do you know your guidelines?Head Neck. 2016 May;38(5):647-52. doi: 10.1002/hed.24359. Epub 2015 Dec 30. Head Neck. 2016. PMID: 26716756 Review.
Cited by
-
What is the predominant etiological factor for Merkel cell carcinoma in Turkey: viral infection or sun exposure?BMC Cancer. 2025 Feb 25;25(1):336. doi: 10.1186/s12885-025-13706-y. BMC Cancer. 2025. PMID: 40001006 Free PMC article.
References
-
- Harms Kelly L., Healy Mark A., Nghiem Paul, Sober Arthur J., Johnson Timothy M., Bichakjian Christopher K., Wong Sandra L. Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System. Oct;2016 Ann Surg Oncol. 23:3564–3571. doi: 10.1245/s10434-016-5266-4. - DOI - PMC - PubMed
-
- Toker C. Trabecular carcinoma of the skin. Jan;1972 Arch Dermatol. 105:107–110. - PubMed
-
- Zwijnenburg Ellen M., Lubeek Satish F. K., Werner Johanna E. M., Amir Avital L., Weijs Willem L. J., Takes Robert P., Pegge Sjoert A. H., Herpen Carla M. L., Adema Gosse J., Kaanders Johannes H. A. M. Merkel Cell Carcinoma: New Trends. Mar;2021 Cancers (Basel) 13:1614–1614. doi: 10.3390/cancers13071614. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical